In: Accounting
Plato Pharmaceuticals Ltd. has invested $100,000 to date in developing a new type of insect repellent. The repellent is now ready for production and sale, and the marketing manager estimates that the product will sell 150,000 bottles a year for the first two years, 170,000 for year three and 200,000 for the next two years. The selling price of the insect repellent will be $6.00 a bottle and the variable costs are estimated to be $3.00 a bottle for Year one. For the next two years the selling price will be $6.50 with variable cost of $3.15 a bottle, and then selling price will be $7.00 after that with a variable cost of $3.55, and $3.80 per bottle. Fixed costs are expected to be $210,000 a year. The figure is made up of $160,000 additional fixed costs and $50,000 fixed costs relating to the existing business that will be apportioned to the new business. In order to produce the repellent, machinery and equipment costing $520,000 will have to be purchased immediately. The estimated residual (salvage) value of this machinery and equipment in five years’ time is $100,000. The business calculates depreciation following CCA rules. The business has a cost of capital of 12%. CCA 30% (50% rule applicable) of depreciation will be used, and taxes are paid at a rate of 40%. Required:
1. Create a cash flow statement for the project for the next 5 years
2. Calculate the net present value.
3. Calculate the internal rate of return.
4. Undertake sensitivity analysis to show how much the following factors would have to change before the project ceased to be feasible. a. The initial cost of machinery and equipment b. Fixed costs c. Variable costs/per bottle d. Selling Price per bottle of repellent e. The residual value of the machinery and equipment
5. Write a statement to explain which of these factors is the most sensitive one.
a. As a first step, depreciation is computed as given below as per cca
Machinery | Amount | Depreciation at 30% | Net |
Cost | 520,000 | ||
year 1 50% | 260,000 | 78,000 | 442,000 |
Year 2 | 442,000 | 132,600 | 309,400 |
Year 3 | 309,400 | 92,820 | 216,580 |
Year 4 | 216,580 | 64,974 | 151,606 |
Year 5 | 151,606 | 45,482 | 106,124 |
Salvage | 100,000 | ||
Loss on sale | 6,124 |
b. The cash flows are calculated as given below
The apportioned fixed cost is ignored as its not relevant for this project.
Particulars | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
Units | 150,000 | 150,000 | 170,000 | 200,000 | 200,000 |
Selling price | 6.00 | 6.50 | 6.50 | 7.00 | 7.00 |
Variable Cost | 3.00 | 3.15 | 3.15 | 3.55 | 3.80 |
Contribution- Selling price minus Variable Cost | 3.00 | 3.35 | 3.35 | 3.45 | 3.20 |
Contribution Value | 450,000 | 502,500 | 569,500 | 690,000 | 640,000 |
Addl Fixed Cost | (160,000) | (160,000) | (160,000) | (160,000) | (160,000) |
Depreciation | (78,000) | (132,600) | (92,820) | (64,974) | (45,482) |
Loss on Sale | - | (6,124) | |||
Net profit | 212,000 | 209,900 | 316,680 | 465,026 | 428,394 |
Tax at 40% | 84,800 | 83,960 | 126,672 | 186,010 | 171,358 |
Operating Cash flow= contribution minus fixed cost |
290,000 | 342,500 | 409,500 | 530,000 | 480,000 |
less Taxes | (84,800) | (83,960) | (126,672) | (186,010) | (171,358) |
Cash flow net of taxes | 205,200 | 258,540 | 282,828 | 343,990 | 308,642 |
c. NPV Calculation
Particulars | Year 0 | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
Investment | (100,000) | |||||
Fixed Asset | (520,000) | |||||
Cash flows net of taxes | 205,200 | 258,540 | 282,828 | 343,990 | 308,642 | |
Salvage value | 100,000 | |||||
Net | (620,000) | 205,200 | 258,540 | 282,828 | 343,990 | 408,642 |
Discounting Factor at 12% | 1.00 | 0.89 | 0.80 | 0.71 | 0.64 | 0.57 |
Discounted Cash flows- DCF | (620,000) | 183,214 | 206,107 | 201,311 | 218,612 | 231,875 |
NPV | 421,118 | <total of dcf> |
d. IRR is calculated using trial and error method. basis that the IRR when NPV is 0 is 33.68% as given below
Particulars | Year 0 | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
Investment | (100,000) | |||||
Fixed Asset | (520,000) | |||||
Cash flows net of taxes | 205,200 | 258,540 | 282,828 | 343,990 | 308,642 | |
Salvage value | 100,000 | |||||
Net | (620,000) | 205,200 | 258,540 | 282,828 | 343,990 | 408,642 |
Discounting Factor at 33.68 | 1.00 | 0.75 | 0.56 | 0.42 |
Related SolutionsPlato Pharmaceuticals Ltd. has invested $100,000 to date in developing a new type of insect repellent....Plato Pharmaceuticals Ltd. has invested $100,000 to date in
developing a new type of insect repellent. The repellent is now
ready for production and sale, and the marketing manager estimates
that the product will sell 150,000 bottles a year for the first two
years, 170,000 for year three and 200,000 for the next two years.
The selling price of the insect repellent will be $6.00 a bottle
and the variable costs are estimated to be $3.00 a bottle for Year...
Plato Pharmaceuticals Ltd. has invested $150,000 to date in developing a new type of insect repellent....Plato Pharmaceuticals Ltd. has invested $150,000 to date in
developing a new type of insect repellent. The repellent is now
ready for production and sale, and the marketing manager estimates
are found in the chart below.
Year
Bottles per year
Selling Price
Variable Cost
1
150,000
$6.00
$3.00
2
165,000
$6.00
$3.15
3
175,000
$6.95
$3.25
4
190,000
$6.95
$3.55
5
190,000
$7.95
$3.60
6
170,000
$7.95
$3.90
Fixed costs (excluding amortization) are expected to be $200,000
a year. The...
4. You are visiting the rainforest, but unfortunately your insect repellent has run out. As a...4. You are visiting the rainforest, but unfortunately
your insect repellent has run out. As a result, at each second, a
mosquito lands on your neck with probability 0.5. If one lands,
with probability 0.2 it bites you, and with probability 0.8 it
never bothers you, independently of other mosquitoes.
a. What is the expected time between successive mosquito bites?
What is the variance of the time between successive mosquito
bites?
b. In addition, a tick lands on your neck...
06. Testing a new insect repellent. (Adapted from McClave, Benson, & Sincich, 12th edition, page 556)....06. Testing a new insect repellent. (Adapted from McClave,
Benson, & Sincich, 12th edition, page 556). A study in the
Journal of the American Mosquito Control Association (Mar. 1995)
investigated whether a tent sprayed with a commercially available
1% permethrin formulation would protest people, both inside and
outside the tent, against biting mosquitoes. Two canvas tents — one
treated with permethrin, the other untreated — were position 25
meters apart on flat, dry ground in an area infested with
mosquitoes....
The company that you manage has invested $5 million in developing a new product, but the...The company that you manage has invested $5 million in
developing a new product, but the development is not quite
finished. At a recent meeting, your salespeople report that the
introduction of competing products has reduced the expected sales
of your new product to $3 million. If it would cost $1 million to
finish development and make the product, you go ahead
and do so. The most you should pay to complete development is
million.
A portfolio has $100,000 invested in bonds and $400,000 invested in stocks. The bonds have an...A portfolio has $100,000 invested in bonds and $400,000 invested
in stocks. The bonds have an expected return of 0.09 a with a
standard deviation of 0.07. The stocks have an expected return of
0.14 with a standard deviation of 0.25. The correlation between the
stocks and bonds is 0.40.
(Round to 3 decimals if necessary)
What is the portfolio weight for the bonds?
Flag this Question
Question 8
Refer to Scenario 3. What is the portfolio weight for the...
New Dawn pharma is considering the acquisition of a small biotech company—Sunset Pharmaceuticals. Sunset is developing...New Dawn pharma is considering the acquisition of a small
biotech company—Sunset Pharmaceuticals. Sunset is developing a new
drug that, if successful, would revolutionize the treatment of
pancreatic and/or liver cancer. Sunset is about to start Phase I of
the clinical testing for the new drug. New Dawn estimates that if
they acquired Sunset the costs associated with Phase I testing
would be around $60 million. They believe the probability of
successful Phase I testing is 30%. Phase 2 testing...
New Dawn pharma is considering the acquisition of a small biotech company—Sunset Pharmaceuticals. Sunset is developing...New Dawn pharma is considering the acquisition of a small
biotech company—Sunset Pharmaceuticals. Sunset is developing a new
drug that, if successful, would revolutionize the treatment of
pancreatic and/or liver cancer. Sunset is about to start Phase I of
the clinical testing for the new drug. New Dawn estimates that if
they acquired Sunset the costs associated with Phase I testing
would be around $60 million. They believe the probability of
successful Phase I testing is 30%. Phase 2 testing...
New Dawn pharma is considering the acquisition of a small biotech company—Sunset Pharmaceuticals. Sunset is developing...New Dawn pharma is considering the acquisition of a small
biotech company—Sunset Pharmaceuticals. Sunset is developing a new
drug that, if successful, would revolutionize the treatment of
pancreatic and/or liver cancer. Sunset is about to start Phase I of
the clinical testing for the new drug. New Dawn estimates that if
they acquired Sunset the costs associated with Phase I testing
would be around $60 million. They believe the probability of
successful Phase I testing is 30%. Phase 2 testing...
Donald Gilmore has $100,000 invested in a 2-stock portfolio. $20,000 is invested in Stock X and...Donald Gilmore has $100,000 invested in a 2-stock portfolio.
$20,000 is invested in Stock X and the remainder is invested in
Stock Y. X's beta is 1.50 and Y's beta is 0.70. What is the
portfolio's beta?
Zacher Co.'s stock has a beta of 1.12, the risk-free rate is
4.25%, and the market risk premium is 5.50%. What is the firm's
required rate of return?
Porter Plumbing's stock had a required return of 14.25% last
year, when the risk-free rate...
ADVERTISEMENT
ADVERTISEMENT
Latest Questions
ADVERTISEMENT
|